Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atavistic Chemotherapy and Immunotherapy in Advanced, Metastatic, and Otherwise Incurable and Lethal Cancers Under Conventional Treatments

NCT02366884 is registered in ClinicalTrials.gov with Dr. Frank Arguello Cancer Clinic as lead sponsor.

NCT NCT02366884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atavistic Chemotherapy and Immunotherapy in Advanced, Metastatic, and Otherwise Incurable and Lethal Cancers Under Conventional Treatments
Lead sponsor
Dr. Frank Arguello Cancer Clinic
Phase
Phase 2
Overall status
Unknown status
Start date
July 26, 2011
Completion date
December 31, 2023
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms